Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management
Open Access
- 17 June 2020
- journal article
- letter
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 35 (3) , 373-375
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment options for COVID-19: The reality and challengesJournal of Microbiology, Immunology and Infection, 2020
- An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking studyJournal of Biomolecular Structure and Dynamics, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- Effects of Phytochemicals on Blood Pressure and Neuroprotection Mediated Via Brain Renin-Angiotensin SystemNutrients, 2019
- Anti-infective Properties of the Golden Spice CurcuminFrontiers in Microbiology, 2019
- Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stressInternational Journal of Molecular Medicine, 2017
- In Vitro Study on Antihypertensive and Antihypercholesterolemic Effects of Curcumin NanoemulsionScientia Pharmaceutica, 2016
- Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in ratsDrug Design, Development and Therapy, 2015
- ACE2 of the heart: From angiotensin I to angiotensin (1–7)Cardiovascular Research, 2007
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005